NeoGenomics 2024年第四季度调整后每股收益$0.04,超出预期的$0.03,销售额为$1.72亿,不及预期的$1.7318亿

财报速递02-18
NeoGenomics(纳斯达克代码:NEO)报告季度每股收益为0.04美元,高于分析师一致预期的0.03美元,超出33.33%。这比去年同期的每股收益增加了33.33%。公司报告季度销售额为1.72亿美元,低于分析师一致预期的1.7318亿美元,低出0.68%。这比去年同期的销售额1.5555亿美元增加了10.57%。

以上内容来自Benzinga Earnings专栏,原文如下:

NeoGenomics (NASDAQ:NEO) reported quarterly earnings of $0.04 per share which beat the analyst consensus estimate of $0.03 by 33.33 percent. This is a 33.33 percent increase over earnings of $0.03 per share from the same period last year. The company reported quarterly sales of $172.00 million which missed the analyst consensus estimate of $173.18 million by 0.68 percent. This is a 10.57 percent increase over sales of $155.55 million the same period last year.

免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白
发表看法